RENEE NADAL: Open Payments
NPI 1063775047 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 8 payments from 5 companies in 2025. Trend: 2023 $199 · 2024 $423 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| SCPHARMACEUTICALS INC. | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| BridgeBio Pharma, Inc. | 1 | $15 |
Products named: LEQVIO, FUROSCIX, JARDIANCE, VERQUVO, Attruby.
Industry payments across NJ — which companies pay providers there.
